The development, optimization and validation of an ELISA bioanalytical method for the determination of Cetuximab in human serum

Analytical Methods

Volumn 1, Issue 2, 2009, Pages 144-148

  Hantash, Jamil ^a   Smidt, Mary ^a   Bowsher, Ronald R ^a  

^a Bioscience Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOANALYTICAL METHODS; CANDIDATE DRUGS; CETUXIMAB; COMBINATION THERAPY; EPIDERMAL GROWTH FACTOR RECEPTORS; HUMAN SERUM; LOW CONCENTRATION LEVELS; LOWER LIMIT OF QUANTITATIONS; RADIATION THERAPY;

ACTIVATION ANALYSIS; BODY FLUIDS; CHEMOTHERAPY; MONOCLONAL ANTIBODIES; RADIATION EFFECTS;

LAWS AND LEGISLATION;

EID: 77953666402     PISSN: 17599660     EISSN: 17599679     Source Type: Journal    
DOI: 10.1039/b9ay00027e     Document Type: Article

References (14)

1. T. Kawamoto J. D. Sato A. Le J. Polikoff G. H. Sato J. Mendelsohn Growth stimulation of A431 cells by EGF: identification of high affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody Proc. Natl. Acad. Sci. U. S. A. 1983 80 1337 41
2. J. D. Sato T. Kawamoto A. D. Le J. Mendelsohn J. Polikoff G. H. Sato Biological effect in vitro of monoclonal antibodies to human EGF receptors Mol. Biol. Med.1 1983 511 29
3. G. N. Gill T. Kawamoto C. Cochet et al. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity J. Biol. Chem. 1984 259 7755 60
4. Y. Humblet Cetuximab: an IgG1 monoclonal antibody for the treatment of epidermal growth factor receptor-expressing tumors Expert Opin. Pharmacother. 2004 5 1621 33
5. N. I. Goldstein M. Prewett Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model Clin. Cancer Res. 1995 1 1311 8
6. R. S. Herbst D. M. Shin Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy Cancer 2002 94 1593 611
7. Z. Fan Y. Lu X. Wu J. Mendelsohn Antibody-induced epidermal growth factor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells J. Biol. Chem. 1994 269 27595 602
8. M. Naramura S. D. Gillies J. Mendelsohn R. A. Reisfeld B. M. Mueller Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma Cancer Immunol. Immunother. 1993 37 343 9
9. G. Carpenter S. Cohen Epidermal growth factor J. Biol. Chem. 1990 265 7709 12
10. F. X. Real W. J. Rettig P. G. Chesa M. R. Melamed L. J. Old J. Mendelsohn Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation Cancer Res. 1986 46 4726 31
11. J. Baselga New technologies in epidermal growth factor receptor targeted cancer therapy Signal 2000 1 12 21
12. A. Wells The epidermal growth factor receptor (EGFR)-a new target in cancer therapy Signal 2000 1 4 11
13. D. Salomon R. Brandt F. Ciardiello N. Normanno Epidermal growth factor related peptides and their receptors in human malignancies Crit. Rev. Oncol. Hematol. 1995 19 183 232
14. G. Masi A. Falcone A. di Paolo G. Allegrini R. Danesi C. Barbara S. Cupini M. Del Tacca A phase I and pharmacokinetic study of Irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreted with 5-fluorouracil or raltitrexed Clin. Cancer Res. 2004 10 1657 1663